362 related articles for article (PubMed ID: 14999283)
1. Inactivation of hCDC4 can cause chromosomal instability.
Rajagopalan H; Jallepalli PV; Rago C; Velculescu VE; Kinzler KW; Vogelstein B; Lengauer C
Nature; 2004 Mar; 428(6978):77-81. PubMed ID: 14999283
[TBL] [Abstract][Full Text] [Related]
2. hCDC4 variation in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Seto KK; Bell RS; Andrulis IL
Cancer Genet Cytogenet; 2006 Sep; 169(2):138-42. PubMed ID: 16938571
[TBL] [Abstract][Full Text] [Related]
3. Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma.
Cassia R; Moreno-Bueno G; Rodríguez-Perales S; Hardisson D; Cigudosa JC; Palacios J
J Pathol; 2003 Dec; 201(4):589-95. PubMed ID: 14648662
[TBL] [Abstract][Full Text] [Related]
4. hCDC4 and genetic instability in cancer.
Rajagopalan H; Lengauer C
Cell Cycle; 2004 Jun; 3(6):693-4. PubMed ID: 15118416
[TBL] [Abstract][Full Text] [Related]
5. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.
Ekholm-Reed S; Spruck CH; Sangfelt O; van Drogen F; Mueller-Holzner E; Widschwendter M; Zetterberg A; Reed SI
Cancer Res; 2004 Feb; 64(3):795-800. PubMed ID: 14871801
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells.
Willmarth NE; Albertson DG; Ethier SP
Breast Cancer Res; 2004; 6(5):R531-9. PubMed ID: 15318934
[TBL] [Abstract][Full Text] [Related]
7. MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression.
Lerner M; Lundgren J; Akhoondi S; Jahn A; Ng HF; Akbari Moqadam F; Oude Vrielink JA; Agami R; Den Boer ML; Grandér D; Sangfelt O
Cell Cycle; 2011 Jul; 10(13):2172-83. PubMed ID: 21597324
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the hCDC4 gene in gastric carcinomas.
Lee JW; Soung YH; Kim HJ; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
Eur J Cancer; 2006 Sep; 42(14):2369-73. PubMed ID: 16824748
[TBL] [Abstract][Full Text] [Related]
9. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability.
Kemp Z; Rowan A; Chambers W; Wortham N; Halford S; Sieber O; Mortensen N; von Herbay A; Gunther T; Ilyas M; Tomlinson I
Cancer Res; 2005 Dec; 65(24):11361-6. PubMed ID: 16357143
[TBL] [Abstract][Full Text] [Related]
10. Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint.
Bailey ML; Singh T; Mero P; Moffat J; Hieter P
Genetics; 2015 Nov; 201(3):885-95. PubMed ID: 26354767
[TBL] [Abstract][Full Text] [Related]
11. Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer.
Kwak EL; Moberg KH; Wahrer DC; Quinn JE; Gilmore PM; Graham CA; Hariharan IK; Harkin DP; Haber DA; Bell DW
Gynecol Oncol; 2005 Jul; 98(1):124-8. PubMed ID: 15913747
[TBL] [Abstract][Full Text] [Related]
12. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A
Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418
[TBL] [Abstract][Full Text] [Related]
13. Fbw7 isoform interaction contributes to cyclin E proteolysis.
Zhang W; Koepp DM
Mol Cancer Res; 2006 Dec; 4(12):935-43. PubMed ID: 17189384
[TBL] [Abstract][Full Text] [Related]
14. The Fbxw7/hCdc4 tumor suppressor in human cancer.
Tan Y; Sangfelt O; Spruck C
Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
[TBL] [Abstract][Full Text] [Related]
16. hCDC4 gene mutations in endometrial cancer.
Spruck CH; Strohmaier H; Sangfelt O; Müller HM; Hubalek M; Müller-Holzner E; Marth C; Widschwendter M; Reed SI
Cancer Res; 2002 Aug; 62(16):4535-9. PubMed ID: 12183400
[TBL] [Abstract][Full Text] [Related]
17. Role of the ubiquitin ligase Fbw7 in cancer progression.
Cheng Y; Li G
Cancer Metastasis Rev; 2012 Jun; 31(1-2):75-87. PubMed ID: 22124735
[TBL] [Abstract][Full Text] [Related]
18. SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis.
Klotz K; Cepeda D; Tan Y; Sun D; Sangfelt O; Spruck C
Exp Cell Res; 2009 Jul; 315(11):1832-9. PubMed ID: 19084516
[TBL] [Abstract][Full Text] [Related]
19. FBXW7 and DNA copy number instability.
Byrd KN; Huey B; Roydasgupta R; Fridlyand J; Snijders AM; Albertson DG
Breast Cancer Res Treat; 2008 May; 109(1):47-54. PubMed ID: 17588203
[TBL] [Abstract][Full Text] [Related]
20. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
